Mark Weinraub

4 days ago | chicagobusiness.com | Mark Weinraub

Private-equity firm Thoma Bravo raised more than $34.4 billion for its investments in software and technology companies across three funds, all of which exceeded their targets. The company said it raised $24.3 billion for its Thoma Bravo Fund XVI, which is focused on large companies in the sector, and $8.1 billion for Thoma Bravo Discover Fund V, which invests in middle-market firms.

5 days ago | chicagobusiness.com | Mark Weinraub

The Illinois General Assembly pushed back by a year implementation of its controversial Interchange Fee Prohibition Act, which would exempt state and local taxes and tips from so-called swipe fees charged by credit card processors. Trade groups representing banks and credit unions have sued the state to block implementation of the law, which was set to go into effect on July 1 before the last minute change by lawmakers.

5 days ago | chicagobusiness.com | Mark Weinraub

JPMorgan Chase is beefing up its Chicago operations, naming two executives to lead local operations and prepare business clients to navigate the current market uncertainty so they are best positioned to move when the economic outlook clears. David Rudolph and Will Kallop will pick up the reins from Curtis Reed, who was promoted to head of JPMorgan’s government banking and health care, higher education and not-for-profit banking teams earlier this year.

1 week ago | chicagobusiness.com | Mark Weinraub

The Trump administration will not provide the American Bar Association with access to its judicial nominees, escalating a fight with the group that traditionally rates the candidates ahead of Senate confirmation hearings. “The ABA no longer functions as a fair arbiter of nominees' qualifications, and its ratings invariably and demonstrably favor nominees put forth by Democratic administrations,” Attorney General Pam Bondi said in a letter to ABA President Bill Bay.

1 week ago | chicagobusiness.com | Mark Weinraub

Private equity firm GTCR’s contested $627 million bid to acquire Surmodics, the first the Trump administration has moved to block, rests on the argument the century-old process the government is relying on to stop the deal is unconstitutional. GTCR, which declined to comment on its strategy beyond its court documents, said the decision about whether the proposed acquisition was legal belonged in federal court rather than an administrative law proceeding overseen by the Federal Trade Commission.